AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16752943 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexylaminolevulinate (all concentrations)
Number of subjects: 12
Study 14737056 — intervention group
Group type: EXPERIMENTAL
Intervention: Humalog (insulin lispro)
Number of subjects: 71
Study 14737056 — intervention group
Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 71
Study 11719362 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbofiban (oral GPIIb/IIIa antagonist)
Number of subjects: 1014
Study 11719362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1014
Study 11719362 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbofiban
Number of subjects: 1014
Study 1402941 — intervention group
Group type: EXPERIMENTAL
Intervention: latex/latex gloving protocol
Number of subjects: 267
Study 1402941 — intervention group
Group type: EXPERIMENTAL
Intervention: latex/cloth gloving protocol
Number of subjects: 267
Study 1402941 — intervention group
Group type: EXPERIMENTAL
Intervention: latex/cloth/latex gloving protocol
Number of subjects: 267
Study 1402941 — intervention group
Group type: COMPARATOR
Intervention: All protocols
Number of subjects: 267
Study 3907640 — intervention group
Group type: COMPARATOR
Intervention: Clenbuterol 10 micrograms
Number of subjects: 12
Study 3907640 — intervention group
Group type: COMPARATOR
Intervention: Clenbuterol 20 micrograms
Number of subjects: 12
Study 3907640 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 8 mg
Number of subjects: 12
Study 3907640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30221305 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training on a tilt table
Number of subjects: 45
Study 30221305 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional upper limb training)
Number of subjects: 45
Study 27178781 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 266
Study 27178781 — intervention group
Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 266
Study 24617449 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP with aPDT
Number of subjects: 90
Study 22699436 — intervention group
Group type: EXPERIMENTAL
Intervention: FSME-IMMUN® Junior
Number of subjects: 0
Study 22699436 — intervention group
Group type: COMPARATOR
Intervention: Encepur® Children
Number of subjects: 0
Study 22699436 — intervention group
Group type: EXPERIMENTAL
Intervention: FSME-IMMUN® Junior (third vaccination)
Number of subjects: 0
Study 22699436 — intervention group
Group type: EXPERIMENTAL
Intervention: FSME-IMMUN® Junior or Encepur® Children (first two vaccinations) followed by FSME-IMMUN Junior® (third vaccination)
Number of subjects: 0
Study 21106812 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cognitive emotion regulation task during fMRI
Number of subjects: 34
Study 21106812 — intervention group
Group type: COMPARATOR
Intervention: Passive viewing task after 15 min delay
Number of subjects: 34
Study 21106812 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cognitive emotion regulation task
Number of subjects: 34
Study 21106812 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlational analyses
Number of subjects: 34
Study 18283224 — intervention group
Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE)
Number of subjects: 39
Study 18283224 — intervention group
Group type: COMPARATOR
Intervention: Strength and balance (SB) training
Number of subjects: 39
Study 15305178 — intervention group
Group type: EXPERIMENTAL
Intervention: trans‐18:1 isomers (T fat)
Number of subjects: 16
Study 15305178 — intervention group
Group type: EXPERIMENTAL
Intervention: saturated fats (P fat and S fat)
Number of subjects: 16
Study 15305178 — intervention group
Group type: COMPARATOR
Intervention: oleic acid (O fat)
Number of subjects: 16
Study 15305178 — intervention group
Group type: COMPARATOR
Intervention: linoleic acid (L fat)
Number of subjects: 16
Study 12794400 — intervention group
Group type: EXPERIMENTAL
Intervention: Discard volume of 2 times the deadspace
Number of subjects: 84
Study 12794400 — intervention group
Group type: EXPERIMENTAL
Intervention: Discard volume of 3.6 times the deadspace
Number of subjects: 84
Study 12794400 — intervention group
Group type: COMPARATOR
Intervention: All discard volumes tested
Number of subjects: 84
Study 10834505 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative hypervolaemic haemodilution using hydroxyethyl starch, followed by intraoperative crystalloid infusion
Number of subjects: 8
Study 10834505 — intervention group
Group type: COMPARATOR
Intervention: Standard intraoperative normovolaemic fluid balance management using crystalloids
Number of subjects: 8
Study 8794967 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-phase oil:water mouthrinse
Number of subjects: 50
Study 8794967 — intervention group
Group type: COMPARATOR
Intervention: Control mouthrinse
Number of subjects: 50
Study 2005168 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injections of corticosteroid and local anaesthesia
Number of subjects: 120
Study 2005168 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation and injection
Number of subjects: 120
Study 2005168 — intervention group
Group type: EXPERIMENTAL
Intervention: Coccygectomy
Number of subjects: 120
Study 2005168 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 120
Study 3927764 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine acetylsalicylate 1.8 g in 10 ml of saline intravenously
Number of subjects: 40
Study 3927764 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection of 10 ml of saline intravenously
Number of subjects: 40
Study 3927764 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 40
Study 31624844 — intervention group
Group type: EXPERIMENTAL
Intervention: phosSNPs (specifically rs3184504 at SH2B3)
Number of subjects: 0
Study 31624844 — intervention group
Group type: EXPERIMENTAL
Intervention: SH2B3 expression level
Number of subjects: 0
Study 31624844 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma beta-2-microglobulin level
Number of subjects: 0
Study 30203763 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine Kouchuang Xiaotong powder
Number of subjects: 140
Study 30203763 — intervention group
Group type: COMPARATOR
Intervention: General routine treatment
Number of subjects: 140
Study 26890802 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm pulsed-dye laser (PDL) with high fluence
Number of subjects: 62
Study 26890802 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm pulsed-dye laser (PDL) with low fluence
Number of subjects: 62
Study 23820566 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 stair (1S) training
Number of subjects: 14
Study 23820566 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 stairs (2S) training
Number of subjects: 14
Study 23820566 — intervention group
Group type: COMPARATOR
Intervention: Control (C) group
Number of subjects: 14
Study 23820566 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-m sprint split power
Number of subjects: 14
Study 22440070 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 174
Study 22440070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 174
Study 21270182 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro mix 75/25 (LM75/25)
Number of subjects: 1818
Study 21270182 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 1818
Study 18044772 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole 50-mg mucoadhesive buccal tablet (MBT)
Number of subjects: 282
Study 18044772 — intervention group
Group type: COMPARATOR
Intervention: Miconazole 500-mg oral gel (MOG)
Number of subjects: 282
Study 16752875 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal and abdominal surgical correction of descensus uteri
Number of subjects: 82
Study 12635389 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.015 mg/kg i.v.
Number of subjects: 60
Study 12635389 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline i.v.)
Number of subjects: 60
Study 10714405 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with epilepsy
Number of subjects: 71
Study 10714405 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 71
Study 8885027 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder efforts for non-attenders
Number of subjects: 2510
Study 8885027 — intervention group
Group type: COMPARATOR
Intervention: Cervical cancer screening participation
Number of subjects: 2510
Study 1391062 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon alpha-2c (6 micrograms, subcutaneously 3 times a week for 6 weeks)
Number of subjects: 33
Study 1391062 — intervention group
Group type: COMPARATOR
Intervention: Recombinant interferon gamma (0.1 mg, subcutaneously 3 times a week for 6 weeks)
Number of subjects: 33
Study 1391062 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 33
Study 3977198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention: Treatment algorithm to increase patient involvement in care during a 20-minute session before a scheduled visit.
Number of subjects: 0
Study 3977198 — intervention group
Group type: COMPARATOR
Intervention: Control: Standard educational session of equal length.
Number of subjects: 0
Study 3977198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention: Treatment algorithm to increase patient involvement in care.
Number of subjects: 0
Study 31155413 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 272
Study 29785878 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI plus medical therapy
Number of subjects: 888
Study 29785878 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 888
Study 27965848 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral feeding plus pre-treatment gastrostomy tube
Number of subjects: 60
Study 27965848 — intervention group
Group type: COMPARATOR
Intervention: Oral feeding plus as-needed nasogastric tube feeding
Number of subjects: 60
Study 25217473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine 2 mg/kg
Number of subjects: 78
Study 25217473 — intervention group
Group type: COMPARATOR
Intervention: Intranasal alfentanil 10 µg/kg
Number of subjects: 78
Study 25217473 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline 1 ml
Number of subjects: 78
Study 23236769 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaochuangao acupoint paste (XAP)
Number of subjects: 90
Study 23236769 — intervention group
Group type: COMPARATOR
Intervention: Hormone
Number of subjects: 90
Study 23236769 — intervention group
Group type: EXPERIMENTAL
Intervention: XAP and Hormone
Number of subjects: 90
Study 23236769 — intervention group
Group type: EXPERIMENTAL
Intervention: All three groups (XAP, Hormone, XAP and Hormone)
Number of subjects: 90
Study 23236769 — intervention group
Group type: EXPERIMENTAL
Intervention: XAP and Hormone vs Hormone
Number of subjects: 90
Study 20078514 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium suppository
Number of subjects: 90
Study 20078514 — intervention group
Group type: COMPARATOR
Intervention: Periprostatic injection of levobupivacaine
Number of subjects: 90
Study 20078514 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac suppository and levobupivacaine
Number of subjects: 90
Study 18562365 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain X-rays
Number of subjects: 60
Study 18562365 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI evaluation
Number of subjects: 60
Study 18562365 — intervention group
Group type: EXPERIMENTAL
Intervention: Frykman Type VI and VIII fractures
Number of subjects: 60
Study 16199711 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 108
Study 16199711 — intervention group
Group type: COMPARATOR
Intervention: Placebo saline solution
Number of subjects: 108
Study 12369732 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761 (120 mg)
Number of subjects: 70
Study 12369732 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 70
Study 9925116 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid infusion (11.97 kJ/min, or 2.86 kcal/min)
Number of subjects: 20
Study 9925116 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion (11.97 kJ/min)
Number of subjects: 20
Study 9925116 — intervention group
Group type: COMPARATOR
Intervention: Control infusion (saline)
Number of subjects: 20
Study 7478706 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 18
Study 7478706 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia
Number of subjects: 18
Study 2297824 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine infusion
Number of subjects: 22
Study 2297824 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline after intracoronary adenosine infusion
Number of subjects: 22
Study 2297824 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 22
Study 2297824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7358209 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroderm ointment base (1% hydrocortisone)
Number of subjects: 0
Study 7358209 — intervention group
Group type: COMPARATOR
Intervention: Established hydrocortisone ointment formulation
Number of subjects: 0
Study 31541747 — intervention group
Group type: EXPERIMENTAL
Intervention: serlopitant
Number of subjects: 14
Study 31541747 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 30202902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary omega-3 fatty acids (fish oil)
Number of subjects: 7
Study 30202902 — intervention group
Group type: COMPARATOR
Intervention: High-ω-3 diet
Number of subjects: 7
Study 28330830 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based survey (n=2300 GPs in France, n=300 GPs in Switzerland)
Number of subjects: 3400
Study 28330830 — intervention group
Group type: COMPARATOR
Intervention: Postal survey (n=400 GPs in France, n=700 GPs in Switzerland)
Number of subjects: 3400
Study 25283139 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamins supplementation (vitamin D3 1200 IU, folic acid 500 μg, vitamin B12 500 μg, vitamin B6 50 mg, calcium carbonate 456 mg)
Number of subjects: 59
Study 25283139 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamins supplementation
Number of subjects: 59
Study 25283139 — intervention group
Group type: COMPARATOR
Intervention: Control group (vitamin D3 plus calcium carbonate)
Number of subjects: 59
Study 23341476 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC)
Number of subjects: 76
Study 23341476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 21884221 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel reasoning task
Number of subjects: 0
Study 21884221 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-culturally validated categories
Number of subjects: 0
Study 20008251 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis stimulating agents (ESAs)
Number of subjects: 0
Study 20008251 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0
Study 20008251 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methyltransferase inhibitors
Number of subjects: 0
Study 20008251 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine
Number of subjects: 0
Study 16865032 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for adolescents (IPT‐A)
Number of subjects: 63
Study 16865032 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual delivered by school‐based mental health clinicians (Control)
Number of subjects: 63
Study 16865032 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IPT‐A and Control
Number of subjects: 63
Study 12626974 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-midazolam
Number of subjects: 25
Study 12626974 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil-midazolam
Number of subjects: 25
Study 10671342 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic genital herpes (n=10)
Number of subjects: 21
Study 10671342 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic genital herpes (n=11)
Number of subjects: 21
Study 10671342 — intervention group
Group type: COMPARATOR
Intervention: Newborns of mothers with HSV
Number of subjects: 21
Study 9058688 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide, 800 microg two times a day
Number of subjects: 31
Study 9058688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 9058688 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 31
Study 8470789 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidat‐Lipuro
Number of subjects: 120
Study 8470789 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnomidate
Number of subjects: 120
Study 8470789 — intervention group
Group type: EXPERIMENTAL
Intervention: Diprivan (Propofol)
Number of subjects: 120
Study 8470789 — intervention group
Group type: EXPERIMENTAL
Intervention: All three groups
Number of subjects: 120
Study 2951261 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin (1, 2, 4, 8 or 16 mg)
Number of subjects: 39
Study 2951261 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (50 or 100 mg)
Number of subjects: 39
Study 29572201 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aid use for the first time during a 6-month auditory training program
Number of subjects: 40
Study 29572201 — intervention group
Group type: COMPARATOR
Intervention: Auditory training (active control)
Number of subjects: 40
Study 27151999 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalytic therapy (PA)
Number of subjects: 3
Study 27151999 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy (PD)
Number of subjects: 3
Study 27151999 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 3
Study 24735894 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice Bag Technique (IBT)
Number of subjects: 150
Study 24735894 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods
Number of subjects: 150
Study 22197217 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis of 37 biomarkers
Number of subjects: 236
Study 22197217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable Cox‐proportional hazard regression analyses
Number of subjects: 236
Study 21040556 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient clinic including a brief group-based educational programme
Number of subjects: 400
Study 21040556 — intervention group
Group type: COMPARATOR
Intervention: Regular care with individual outpatient consultation with a rheumatologist (treatment as usual)
Number of subjects: 400
Study 18673365 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg QW
Number of subjects: 142
Study 18673365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 15307859 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic balloon dilation (EPBD)
Number of subjects: 0
Study 15307859 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic biliary sphincterotomy (EST)
Number of subjects: 0
Study 11124745 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% triacylglycerol emulsion infusion
Number of subjects: 32
Study 11124745 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 32
Study 9643859 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc lozenges, 10 mg, orally dissolved, 5 times a day (grades 1-6) or 6 times a day (grades 7-12)
Number of subjects: 249
Study 9643859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study 9643859 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc lozenges
Number of subjects: 249
Study 8163780 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Diurnal Variation (MDV)
Number of subjects: 74
Study 8163780 — intervention group
Group type: EXPERIMENTAL
Intervention: MDV
Number of subjects: 74
Study 8163780 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication requirements
Number of subjects: 74
Study 8163780 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine reactivity
Number of subjects: 74
Study 3278366 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 222
Study 3278366 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid
Number of subjects: 222
Study 3278366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 27178060 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Brain, Body, and Social (IBBS) intervention
Number of subjects: 92
Study 27178060 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 92
Study 29223688 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler imaging
Number of subjects: 150
Study 29223688 — intervention group
Group type: COMPARATOR
Intervention: Standard ultrasound imaging
Number of subjects: 150
Study 27686234 — intervention group
Group type: EXPERIMENTAL
Intervention: Single incision sleeve gastrectomy (SI)
Number of subjects: 130
Study 27686234 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic sleeve gastrectomy (CL)
Number of subjects: 130
Study 25662105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 86
Study 25662105 — intervention group
Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 86
Study 24216139 — intervention group
Group type: EXPERIMENTAL
Intervention: ColoDATES Web (interactive decision aid)
Number of subjects: 600
Study 24216139 — intervention group
Group type: COMPARATOR
Intervention: Non-interactive website (control)
Number of subjects: 600
Study 21364895 — intervention group
Group type: EXPERIMENTAL
Intervention: Chord progressions with varying conditional probabilities
Number of subjects: 0
Study 21364895 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical training
Number of subjects: 0
Study 21364895 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral measures in non-musicians
Number of subjects: 0
Study 18272934 — intervention group
Group type: EXPERIMENTAL
Intervention: Ex+D (cycling exercise at 65% of oxygen consumption reserve, 200 kcal)
Number of subjects: 20